Surgical margin in soft tissue sarcoma The Scandinavian Sarcoma Group experience
- 1 January 1989
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 60 (6) , 687-692
- https://doi.org/10.3109/17453678909149605
Abstract
Two-hundred and forty adult patients with a high-grade soft tissue sarcoma were treated surgically in 18 hospitals participating in the Scandinavian Sarcoma Group Protocol 1. The patients were randomized to either postoperative doxorubicin or control; patients whose surgical margin was judged marginal also received radiotherapy. The outcome after different surgical margins was analyzed in 185 tumors of Grades III or IV in the extremities. The total cumulative local tumor control was 91 percent (168 of 185) after a median of 47 months. The cumulative local control rates in the surgical groups were: compartmental or wide amputation–37/37 (100 percent), compartmental local excision–23/24 (96 percent), wide local excision–77/84 (92 percent), marginal excision and radiotherapy–19/21 (90 percent), and marginal excision alone (reevaluated margin)–12/19 (63 percent, significantly lower than others). The risk of local recurrence was 13 times higher after marginal than after compartmental surgery (P = 0.02) and 3 times higher if the tumor was larger than 10 cm (P = 0.05). The treatment with doxorubicin did not influence the risk of local recurrence. The survival rates did not differ significantly in the groups.This publication has 10 references indexed in Scilit:
- Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.Journal of Clinical Oncology, 1989
- Prognostic factors for local recurrence and survival in patients with localized extremity soft‐tissue sarcomaSeminars in Surgical Oncology, 1988
- Surgical margins for soft-tissue sarcoma.Journal of Bone and Joint Surgery, 1987
- A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations.Journal of Clinical Oncology, 1986
- Feasibility of limb salvage and survival in soft tissue sarcomasCancer, 1986
- Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.Journal of Clinical Oncology, 1984
- The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.Journal of Bone and Joint Surgery, 1982
- The Treatment of Soft-tissue Sarcomas of the ExtremitiesAnnals of Surgery, 1982